English | Español
Press release submission | Sep 27, 2018

MONTEFIORE HEALTH SYSTEM: Montefiore Earns Highest Status in Stroke Care
Press release submission | Sep 27, 2018

ABBOTT CORPORATION: Receives CE Mark for First Troponin Test to Help Predict the Chance of Heart Attack in Apparently Healthy Adults Potentially Months to Years in Advance
Press release submission | Sep 23, 2018

ABBVIE: Announces $5 Million Donation to Family Reach to Support Children Battling Cancer and Their Families
Press release submission | Sep 23, 2018

ELI LILLY AND COMPANY: Lilly Receives Positive CHMP Opinion for Emgality™ (galcanezumab) for the Prophylaxis of Migraine in Adults
Press release submission | Sep 16, 2018

GENENTECH INC: FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
Press release submission | Sep 16, 2018

ASTRAZENECA: US FDA approves LUMOXITI™ (moxetumomab pasudotox-tdfk) for certain patients with relapsed or refractory hairy cell leukemia

Press release submission | Sep 5, 2018

LIVONGO HEALTH: Becomes First Comprehensive Diabetes Offering to Add Abbott’s FreeStyle® Libre Pro System to Platform
Press release submission | Sep 5, 2018

NUVASIVE INC: To Feature Lateral Single-Position Surgery And Surgical Intelligence At SMISS Annual Forum

Trending
+ Pharmaceuticals
Patient Daily | Jun 18, 2025

ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
+ Pharmaceuticals
Patient Daily | Jun 17, 2025

Founder of ReKlaim Health: '340B drug discounts profit from the poor'
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

FDA loophole lets low-quality drugs from China and India flood U.S. market, while American manufacturers are held to higher standards